Pobierz materiał i Publikuj za darmo
Podstawa prawna: Prairie Mining Limited (Company) announces that 5,775,000 Performance Rights have been issued today to keys employees and consultants of the Company pursuant to the Company's Performance Rights and long term incentive plan.
For further information, please contact:
Prairie Mining Limited Tel: +44 207 478 3900
Ben Stoikovich, Chief Executive Officer Email: info@pdz.com.au
Sapan Ghai, Head of Corporate Development
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity
PRAIRIE MINING LIMITED
ABN
23 008 677 852
We (the entity) give ASX the following information.
Part 1 All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities issued or to be issued Performance share rights
2 Number of +securities issued or to be issued (if known) or maximum number which may be issued 5,775,000
3 Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) Performance share rights which do not have an exercise price but are subject to various performance conditions (including: Jan Karski Mine Concession; Jan Karski Construction; Debiensko Feasibility Study; and Debiensko Construction Milestones) to be satisfied prior to the relevant expiry dates between 31 December 2017 and 31 December 2020
4 Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?
If the additional +securities do not rank equally, please state:
• the date from which they do
• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment No - not listed
5 Issue price or consideration Nil - see below
6 Purpose of the issue
(If issued as consideration for the acquisition of assets, clearly identify those assets)
Issue of performance share rights to key employees and consultants of the Company
6a Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?
If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i No
6b The date the security holder resolution under rule 7.1A was passed Not applicable
6c Number of +securities issued without security holder approval under rule 7.1 Not applicable
6d Number of +securities issued with security holder approval under rule 7.1A Not applicable
6e Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)
Not applicable
6f Number of +securities issued under an exception in rule 7.2 Not applicable
6g If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. Not applicable
6h If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements Not applicable
6i Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements Rule 7.1 - 24,699,345
Rule 7.1A - Not applicable
7 +Issue dates
Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B. 25 August 2017
Number +Class
8 Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)
167,498,969 Ordinary Shares
Number +Class
9 Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)
1,400,000
200,000
400,000
700,000
12,575,000
44,776,120
22,388,060
5,711,805 Options exercisable at $0.45 each on or before 30 June 2018
Options exercisable at $0.50 each on or before 31 March 2020
Options exercisable at $0.60 each on or before 31 March 2020
Options exercisable at $0.80 each on or before 31 March 2020
Performance share rights subject to various performance conditions to be satisfied prior to relevant milestones or expiry dates between 31 December 2017 and 31 December 2020
Put and call option issued in connection with a convertible note with a principal amount of $15,000,000, exchangeable into 44,776,120 ordinary shares at a conversion price of $0.335 per share with no expiry date ("Loan Note 1").
Agreement to issue unlisted options exercisable at $0.60 each expiring 3 years after conversion of Loan Note 1.
Convertible loan note with a principal amount of $2,627,430, convertible into 5,711,805 ordinary shares at a conversion price of $0.46 per share with no expiry date ("Loan Note 2")
10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests) Not applicable
Part 2 Pro rata issue
11 Is security holder approval required?
Not applicable
12 Is the issue renounceable or non-renounceable? Not applicable
13 Ratio in which the +securities will be offered Not applicable
14 +Class of +securities to which the offer relates Not applicable
15 +Record date to determine entitlements Not applicable
16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? Not applicable
17 Policy for deciding entitlements in relation to fractions
Not applicable
18 Names of countries in which the entity has security holders who will not be sent new offer documents
Note: Security holders must be told how their entitlements are to be dealt with.
Cross reference: rule 7.7. Not applicable
19 Closing date for receipt of acceptances or renunciations Not applicable
20 Names of any underwriters
Not applicable
21 Amount of any underwriting fee or commission Not applicable
22 Names of any brokers to the issue
Not applicable
23 Fee or commission payable to the broker to the issue Not applicable
24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders Not applicable
25 If the issue is contingent on security holders' approval, the date of the meeting Not applicable
26 Date entitlement and acceptance form and offer documents will be sent to persons entitled Not applicable
27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders Not applicable
28 Date rights trading will begin (if applicable) Not applicable
29 Date rights trading will end (if applicable)
Not applicable
30 How do security holders sell their entitlements in full through a broker? Not applicable
31 How do security holders sell part of their entitlements through a broker and accept for the balance? Not applicable
32 How do security holders dispose of their entitlements (except by sale through a broker)? Not applicable
33 +Issue date
Not applicable
Part 3 Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of +securities
(tick one)
(a) 0
+Securities described in Part 1
(b) 0
All other +securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
35 0
If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders
36 0
If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 0
A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of +securities for which +quotation is sought
Not applicable
39 +Class of +securities for which quotation is sought
Not applicable
40 Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?
If the additional +securities do not rank equally, please state:
• the date from which they do
• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment Not applicable
41 Reason for request for quotation now
Example: In the case of restricted securities, end of restriction period
(if issued upon conversion of another +security, clearly identify that other +security)
Not applicable
Number +Class
42 Number and +class of all +securities quoted on ASX (including the +securities in clause 38)
Not applicable Not applicable
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
• The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
• There is no reason why those +securities should not be granted +quotation.
• An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
• If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
[signed electronically without signature]
Sign here: ............................................................ Date: 25 August 2017
(Director/Company secretary)
Print name: Dylan Browne
== == == == ==
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement capacity is calculated
Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue 151,608,969
Add the following:
• Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2
• Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval
• Number of partly paid +ordinary securities that became fully paid in that 12 month period
Note:
• Include only ordinary securities here - other classes of equity securities cannot be added
• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed
• It may be useful to set out issues of securities on different dates as separate line items
11,500,000 Ordinary shares (3 April 2017)
570,000 ordinary shares (9 June 2017)
2,110,000 ordinary shares (16 June 2017)
1,340,000 ordinary shares (6 July 2017)
Subtract the number of fully paid +ordinary securities cancelled during that 12 month period Nil
"A" 167,128,969
Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be changed]
Multiply "A" by 0.15 25,069,345
Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used
Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule 7.1 or rule 7.4
Note:
• This applies to equity securities, unless specifically excluded - not just ordinary securities
• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed
• It may be useful to set out issues of securities on different dates as separate line items
250,000 Ordinary shares (2 Dec 2016)
120,000 Ordinary shares (17 Mar 2017)
"C" 370,000
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1
"A" x 0.15
Note: number must be same as shown in Step 2 25,069,345
Subtract "C"
Note: number must be same as shown in Step 3 370,000
Total ["A" x 0.15] - "C" 24,699,345
[Note: this is the remaining placement capacity under rule 7.1]
Part 2
Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement capacity is calculated
"A"
Note: number must be same as shown in Step 1 of Part 1 Not applicable
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot be changed
Multiply "A" by 0.10 Not applicable
Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used
Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A
Notes:
• This applies to equity securities - not just ordinary securities
• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed
• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained
• It may be useful to set out issues of securities on different dates as separate line items Not applicable
"E" Not applicable
Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A
"A" x 0.10
Note: number must be same as shown in Step 2 Not applicable
Subtract "E"
Note: number must be same as shown in Step 3 Not applicable
Total ["A" x 0.10] - "E" Not applicable
Note: this is the remaining placement capacity under rule 7.1A
Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1
kom espi zdz
Pobierz materiał i Publikuj za darmo
bezpośredni link do materiału
Data publikacji | 25.08.2017, 11:22 |
Źródło informacji | ESPI |
Zastrzeżenie | Za materiał opublikowany w serwisie PAP MediaRoom odpowiedzialność ponosi – z zastrzeżeniem postanowień art. 42 ust. 2 ustawy prawo prasowe – jego nadawca, wskazany każdorazowo jako „źródło informacji”. Informacje podpisane źródłem „PAP MediaRoom” są opracowywane przez dziennikarzy PAP we współpracy z firmami lub instytucjami – w ramach umów na obsługę medialną. Wszystkie materiały opublikowane w serwisie PAP MediaRoom mogą być bezpłatnie wykorzystywane przez media. |